GE HealthCare Technologies Inc.

NasdaqGS:GEHC

Sector

🏥 Health Care

Industries

🩺 Medical Instruments

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

💻 Telehealth

Location

United States

Market Cap

USD 32.64 B

Share Price

USD 71.28

Avg Daily Volume

4,923,420

Change (1 day)

-0.85%

Change (1 year)

-10.27%

Change (YTD)

-8.83%

GE HealthCare Technologies Inc. Share Price Year-To-Date (YTD) return on June 20, 2025: -8.83%

GE HealthCare Technologies Inc. Share Price Year-To-Date (YTD) return is -8.83% on June 20, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.

GE HealthCare Technologies Inc. 52-week low Share Price is USD 93.85 on June 20, 2025, which is 31.66% above the current Share Price.
GE HealthCare Technologies Inc. 52-week low Share Price is USD 58.75 on June 20, 2025, which is -17.58% below the current Share Price.
GE HealthCare Technologies Inc. average Share Price for the last 52 weeks is USD 81.28.

Daily

From:

To:

Zoom:

Key data

Date	Share Price Year-To-Date (YTD) return	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)

NasdaqGS: GEHC

GE HealthCare Technologies Inc.

CEO	Mr. Peter J. Arduini
IPO Date	Dec. 15, 2022
Location	United States
Headquarters	500 West Monroe Street
Employees	53,000
Sector	🏥 Health Care
Industries Medical Instruments 🧬 Biotechnology 🔬 Clinical Trials 💊 Pharmaceuticals 💻 Telehealth

Description

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.